Posted by Martin February 02, 2026

Closing BTCI, opening BITI

Closing BTCI, opening BITI

Bitcoin has its bloodbath and we got stopped out from the long position BTCI this morning. Because the trend of Bitcoin is negative despite this morning attempt to bounce, I am opening a short Bitcoin position using BITI: I will be placing a stop loss on the new BITI position.  

Posted by Martin January 27, 2026

Adding Coinbase (COIN) to growth portfolio

Adding Coinbase (COIN) to growth portfolio

In my spreadsheet, you can see growth trades based on AI screener. It is somewhat an experiment to me. That is why I keep positions extremely small. Here are the rules: If a stock shows on the screener list, I buy the symbol. I buy approximately equal dollar position to match others. After I buy, Continue reading →

Posted by Martin January 17, 2026

01/12/2026 New Trade TQQQ LEAPS (OPEN)

01/12/2026 New Trade TQQQ LEAPS (OPEN)

I use TQQQ (3x leveraged ETF) as an aggressive growth vehicle to grow the account fast. This leveraged instrument goes up 3 times when Nasdaq goes up, but it also goes down 3 times when the Nasdaq goes down. So drawdowns can be brutal. This ETF is also not supposed to be a long term Continue reading →

Posted by Martin December 29, 2025

12/29/2025 New Trade NVDA LEAPS (OPEN)

12/29/2025 New Trade NVDA LEAPS (OPEN)

We are opening LEAPS against Nvidia (NVDA) so we can start selling covered calls against the position while still being exposed to the stock’s growth. Instead of owning 100 shares of NVDA which would cost us $18,824 we could buy 1 LEAPS contract for $8,370 instead, gain the same (or similar) exposure to the stock’s Continue reading →

Posted by Martin December 29, 2025

12/29/2025 New Trade AAPL LEAPS (OPEN)

12/29/2025 New Trade AAPL LEAPS (OPEN)

We are opening LEAPS against Apple (AAPL) so we can start selling covered calls against the position while still being exposed to the stock’s growth. Instead of owning 100 shares of AAPL which would cost us $27,380 we could buy 1 LEAPS contract for $9,920 instead, gain the same (or similar) exposure to the stock’s Continue reading →